New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. / Müllertz, Anette; Ogbonna, Anayo; Ren, Shan; Rades, Thomas.

In: Journal of Pharmacy and Pharmacology, Vol. 62, No. 11, 2010, p. 1622-1636.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Müllertz, A, Ogbonna, A, Ren, S & Rades, T 2010, 'New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs', Journal of Pharmacy and Pharmacology, vol. 62, no. 11, pp. 1622-1636. https://doi.org/10.1111/j.2042-7158.2010.01107.x

APA

Müllertz, A., Ogbonna, A., Ren, S., & Rades, T. (2010). New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. Journal of Pharmacy and Pharmacology, 62(11), 1622-1636. https://doi.org/10.1111/j.2042-7158.2010.01107.x

Vancouver

Müllertz A, Ogbonna A, Ren S, Rades T. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. Journal of Pharmacy and Pharmacology. 2010;62(11):1622-1636. https://doi.org/10.1111/j.2042-7158.2010.01107.x

Author

Müllertz, Anette ; Ogbonna, Anayo ; Ren, Shan ; Rades, Thomas. / New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. In: Journal of Pharmacy and Pharmacology. 2010 ; Vol. 62, No. 11. pp. 1622-1636.

Bibtex

@article{4de664e755f04129a5eea03c80002c63,
title = "New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs",
abstract = "The aim of this review is to highlight relevant considerations when implementing a rational strategy for the development of lipid and surfactant based drug delivery system and to discuss shortcomings and challenges to the current classification of these delivery systems. We also aim to offer suggestions for an improved classification system that will accommodate lipid based formulations that are not currently accommodated in the lipid formulation classification system.",
keywords = "Administration, Oral, Biological Availability, Drug Delivery Systems, Emulsions, Lipids, Pharmaceutical Preparations, Solubility, Surface-Active Agents, Technology, Pharmaceutical",
author = "Anette M{\"u}llertz and Anayo Ogbonna and Shan Ren and Thomas Rades",
note = "{\textcopyright} 2010 The Authors. Journal compilation {\textcopyright} 2010 Royal Pharmaceutical Society of Great Britain.",
year = "2010",
doi = "10.1111/j.2042-7158.2010.01107.x",
language = "English",
volume = "62",
pages = "1622--1636",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "JohnWiley & Sons Ltd",
number = "11",

}

RIS

TY - JOUR

T1 - New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs

AU - Müllertz, Anette

AU - Ogbonna, Anayo

AU - Ren, Shan

AU - Rades, Thomas

N1 - © 2010 The Authors. Journal compilation © 2010 Royal Pharmaceutical Society of Great Britain.

PY - 2010

Y1 - 2010

N2 - The aim of this review is to highlight relevant considerations when implementing a rational strategy for the development of lipid and surfactant based drug delivery system and to discuss shortcomings and challenges to the current classification of these delivery systems. We also aim to offer suggestions for an improved classification system that will accommodate lipid based formulations that are not currently accommodated in the lipid formulation classification system.

AB - The aim of this review is to highlight relevant considerations when implementing a rational strategy for the development of lipid and surfactant based drug delivery system and to discuss shortcomings and challenges to the current classification of these delivery systems. We also aim to offer suggestions for an improved classification system that will accommodate lipid based formulations that are not currently accommodated in the lipid formulation classification system.

KW - Administration, Oral

KW - Biological Availability

KW - Drug Delivery Systems

KW - Emulsions

KW - Lipids

KW - Pharmaceutical Preparations

KW - Solubility

KW - Surface-Active Agents

KW - Technology, Pharmaceutical

U2 - 10.1111/j.2042-7158.2010.01107.x

DO - 10.1111/j.2042-7158.2010.01107.x

M3 - Journal article

C2 - 21039546

VL - 62

SP - 1622

EP - 1636

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 11

ER -

ID: 33024595